ImmunoGen Inc (IMGN)
US45253H1014 - Common Stock
ChartMill assigns a Buy % Consensus number of 71% to IMGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.69. This target is 1.46% above the current price.
IMGN was analyzed by 19 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about IMGN.
In the previous month the buy percentage consensus was at a similar level.
IMGN was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-04 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2023-12-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-12-01 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-12-01 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2023-12-01 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2023-12-01 | Jefferies | Downgrade | Buy -> Hold |
| 2023-11-30 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-20 | Goldman Sachs | Initiate | Neutral |
| 2023-11-09 | Deutsche Bank | Initiate | Buy |
| 2023-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-06 | Oppenheimer | Initiate | Perform |
| 2023-09-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-12 | Barclays | Maintains | Overweight |
| 2023-06-12 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-06-06 | Truist Securities | Maintains | Buy -> Buy |
| 2023-06-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-05-03 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-05-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-23 | JP Morgan | Maintains | Neutral |
| 2022-12-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-21 | Truist Securities | Initiate | Buy |
| 2022-11-16 | BMO Capital | Maintains | Outperform |
| 2022-11-16 | Canaccord Genuity | Maintains | Buy |